MAPK8 and Alzheimer disease: Moreover, the AD + AA-L and AD + AA-H group of the p-p38 (25% and 52%, respectively), p-JNK (35% and 90%, respectively), and p-ERK1/2 (38% and 33%, respectively) levels were decreased compared with that in the AD-only group.